Related Experiment Video

Updated: May 28, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors

Francesco Dituri1, Antonio Mazzocca, Gianluigi Giannelli

  • 1Department of Emergency and Organ Transplantation, Section of Internal Medicine, Allergology and Clinical Immunology, University of Bari Medical School, 70124 Bari, Italy. dituri-fr.biologia@libero.it

Clinical & Developmental Immunology
|November 3, 2011
PubMed

Insights

The phosphatidylinositol 3-kinase (PI3K) pathway has dual roles in cancer immunity, impacting both anti-tumor responses and cancer cell evasion. Targeting PI3K may offer benefits but also presents challenges for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor surveillance depends on immune cell recognition of cancer antigens.
  • Dysregulated cytokine release and cancer cell evasion mechanisms can impair anti-tumor immunity.
  • The phosphatidylinositol 3-kinase (PI3K) pathway is crucial for cellular processes, including immune responses and cancer development.

Purpose of the Study:

  • To review the contradictory roles of the PI3K pathway in anti-tumor immune responses.
  • To examine how PI3K contributes to cancer cell malignancy and immune evasion.
  • To discuss the potential benefits and drawbacks of PI3K-targeting agents in cancer immunotherapy.

Main Methods:

  • Literature review of existing research on the PI3K pathway in cancer immunology.
  • Analysis of studies detailing PI3K's involvement in immune cell function and cancer cell behavior.
  • Discussion of pharmacological agents targeting the PI3K pathway in the context of cancer treatment.

Main Results:

  • The PI3K pathway plays a complex role, supporting anti-tumor immunity while also facilitating cancer cell survival and immune escape.
  • Evidence suggests PI3K is implicated in cancer cell malignant traits and their ability to evade immune detection.
  • Targeting the PI3K pathway presents a potential therapeutic strategy with both advantages and disadvantages for anti-cancer immunology.

Conclusions:

  • The PI3K pathway is a critical regulator of the interplay between cancer cells and the immune system.
  • Understanding PI3K's dual functions is essential for developing effective cancer immunotherapies.
  • Further research is needed to optimize the use of PI3K inhibitors to enhance anti-tumor immune responses while minimizing adverse effects.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...